Click Holdings Limited (NASDAQ:CLIK) Short Interest Down 35.1% in January

Click Holdings Limited (NASDAQ:CLIK) saw a large drop in short interest during the month of January. As of January 30th, there was short interest totaling 2,237 shares, a drop of 35.1% from the January 15th total of 3,446 shares. Based on an average daily trading volume, of 6,248 shares, the days-to-cover ratio is currently 0.4 days. Currently, 0.2% of the shares of the company are sold short. Currently, 0.2% of the shares of the company are sold short. Based on an average daily trading volume, of 6,248 shares, the days-to-cover ratio is currently 0.4 days.

Analyst Ratings Changes

Separately, Weiss Ratings reiterated a “sell (d)” rating on shares of Click in a research note on Monday, December 29th. One analyst has rated the stock with a Sell rating, According to MarketBeat, the stock presently has an average rating of “Sell”.

Click Stock Performance

Shares of NASDAQ CLIK traded down $0.15 during midday trading on Friday, hitting $3.43. 8,881 shares of the company’s stock were exchanged, compared to its average volume of 6,345. Click has a twelve month low of $3.10 and a twelve month high of $102.90. The stock’s 50 day moving average price is $5.03 and its 200-day moving average price is $7.28.

About Click

Click Therapeutics, Inc (NASDAQ: CLIK) is a clinical-stage digital therapeutics company developing software-based treatments for neurological, psychiatric and chronic diseases. Its platform delivers prescription digital therapies via mobile and web applications, combining evidence-based cognitive behavioral interventions, digital monitoring tools and patient engagement techniques. Click’s approach is designed to complement or extend traditional pharmacological and behavioral treatments for conditions such as major depressive disorder, insomnia and tobacco use disorder.

Founded in 2014, Click has progressed multiple programs through randomized controlled trials and regulatory review.